NORTH HAVEN, Conn.--(BUSINESS WIRE)--Jun. 19, 2009--
Covidien (NYSE: COV), a leading global provider of healthcare products,
will showcase a number of its most recent innovations in minimally
invasive surgery (MIS) and soft tissue repair at the American Society
for Metabolic & Bariatric Surgery (ASMBS) annual meeting on June 21-26,
2009, in Grapevine, Texas. These state-of-the-art innovations underscore
Covidien’s commitment to working in partnership with the surgical
community to develop surgical instruments designed to optimize patient
A number of prominent surgeons also will address key industry issues at
the Covidien exhibit, including sleeve gastrectomy, the impact of
bariatric surgery on patients with Type 2 diabetes, Allergan LAP-BAND
AP® Adjustable Gastric Banding System and the next generation of MIS
Located at booth 125, Covidien will present a broad range of
laparoscopic instrumentation, electrosurgical devices, surgical
staplers, mesh products and other specialized solutions. Of note is the
SILS™ PORT, a single, flexible port that can be fitted through a small
incision in the umbilicus and can accommodate up to three laparoscopic
instruments. This progressive approach allows for easy specimen removal,
while providing greater stability, support and maneuverability for hand
instruments. Additional information on SILS PORT is available at www.sils.com.
Other products on display at Covidien’s booth include:
Duet TRS™ Reload – an endoscopic stapler preloaded with tissue
reinforcement material, which is a synthetic absorbable polymer that
remains flat and secure during placement on and manipulation of
tissue. This integrated device provides surgeons with the option of
using tissue reinforcement without any additional steps. More
information on Duet TRS Reload can be found by visiting www.duettrs.com.
ForceTriad™ – an energy platform that delivers monopolar,
bipolar and next-generation LigaSure™ tissue fusion in one integrated,
software-driven unit. The software can be updated remotely through a
secure Internet connection, ensuring that the platform is always
up-to-date with the technological enhancements. For additional
information about the ForceTriad, please visit www.forcetriad.com.
Force TriVerse™ – a single-use electrosurgical instrument that
provides surgeons with a range of options for precise control and
tissue effect. The device provides access to three distinct tissue
effect modes: Cut, Coag and Valleylab™ mode, which offers monopolar
hemostasis and dissection while using a lower-power setting, resulting
in less char, thermal spread and arcing than a traditional Coagulation
mode. To learn more about the Force TriVerse, please visit www.forcetriad.com.
Kendall SCD™ Sequential Compression System – a fully
transportable vascular compression system with specific FDA-cleared
indication for use for DVT and PE prophylaxis for the at-risk patient,
including the bariatric and morbidly obese patient. The large and
extra-large Kendall SCD compression sleeves are designed to fit and
protect obese patients from DVT. The system delivers clinically-proven
sequential, gradient, circumferential compression that clinicians have
come to know and trust. Additional information on the SCD Sequential
Compression System is available at www.kendallvasculartherapy.com.
Allergan LAP-BAND AP® Adjustable Gastric
Banding System – approved by the FDA in June 2001 for severely
obese adults with a Body Mass Index (BMI) of 40 or more and for adults
with a BMI of at least 35 plus at least one severe obesity-related
health condition, such as Type 2 diabetes, hypertension or asthma.
Used in more than 450,000 procedures worldwide, the LAP-BAND®
System was developed to facilitate long-term weight loss and reduce
the health risks associated with severe and morbid obesity.
LigaSure Advance™ – a multifunctional 5 mm laparoscopic
instrument that offers surgeons fingertip control of both tissue
fusion and monopolar dissection. This device enables surgeons to
create fusion cycles in two to four seconds, and to access Valleylab
mode, the unique energy modality that delivers dissection and
hemostasis. More information about the LigaSure Advance can be found
Parietex ProGrip™ – the first bicomponent mesh of monofilament
polyester and a resorbable polylactic acid gripping system for truly
tension-free repair. This secure, biocompatible solution is positioned
and placed in the same manner as in a standard open patch repair.
Suture fixation is not required, but used at the discretion of the
surgeon. Visit www.covidien.com/progrip
for further information on Parietex ProGrip.
Permacol™ Biologic Implant – a biologic mesh for hernia
and abdominal wall repair that combines the clinical advantages of a
biologic with the durability, strength, size and intraoperative
efficiency of a synthetic in an acellular porcine dermal implant. This
implant utilizes a unique crosslinking formula that adds to the
durability of the repair while providing the bioavailability expected
of a biologic implant. Further information on Permacol biologic
implant can be downloaded at www.covidien.com/hernia.
Valleylab Solid Lap Electrodes – an electrosurgical accessory
available in multiple configurations to allow surgeons to customize
for different laparoscopic procedures. The electrodes feature an
extended tip that delivers energy safely and consistently, and reduces
the potential of unintended site burns.
Versaport™ Plus Bladeless Trocars – a bladeless access device
that provides enhanced precision and control, low insertion force, a
small fascial defect and superior port fixation. Leveraging advanced
secure entry technology, the trocars can be used in conventional and
advanced laparoscopic procedures in general, bariatric, colon and
rectal, gynecological and urological surgery. To learn more about
Versaport Plus Bladeless Trocars, please visit www.bladelesstrocar.com.
Other featured products – AbsorbaTack™ 5mm Fixation
DST Series™ EEA™ stapler and OrVil™ device and Parietex™ PCO (www.covidien.com/syneture).
is a leading global healthcare products company that creates innovative
medical solutions for better patient outcomes and delivers value through
clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines in four
segments: Medical Devices, Imaging Solutions, Pharmaceutical Products
and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien
has more than 41,000 employees worldwide in 59 countries, and its
products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Diana Sousa, 203-492-7610
Lannum, CFA, 508-452-4343